RELAPSES in Danish translation

• tilbagefald
• attakker
• relapser
• opblussen

Examples of using Relapses in English and their translations into Danish

The Bad Dogs, the Relapses, and a lot of them. There's Guachalokos, Babylokos, the Goblins.
Perros Gachos, Caidos og mange andre. Der er Guachalocos, Babylocos, Duendes.

Progression accompanied relapses for 1 EDSS during 12 months.
Progression praćena relapsima za 1 EDSS under 12 måneder.

We wanted to develop a tele medical method to detect relapses.
Vi ville gerne udvikle en telemedicinsk metode til at varsle om tilbagefald.

of clinical relapses.
i antallet af kliniske recidiver.

There is no evidence of Extavia having an effect on the duration of relapses.
Det er ikke påvist, at Extavia påvirker varigheden af relapserne.

There would be no relapses.
Du ville ikke falde i.

There is no evidence of Betaferon having an effect on the duration of relapses.
Det er ikke påvist, at Betaferon har virkning på varigheden af relapserne.

All right, I will leave Grayson here with you… in case she relapses.
Godt. Jeg lader Grayson blive her. I tilfælde af, at hun får tilbagefald.

Some effect on progression of disability could be seen only in the patients who had relapses in the two years before the start of the study.
Kun hos de patienter, der ved undersøgelsens start havde haft attakker i de to foregående år, kunne der observeres en invaliditetsforværrende virkning.

Corticosteroid or ACTH treatment of relapses for periods of up to 28 days has been well tolerated in patients receiving Extavia.
Kortikosteroid- eller ACTH- behandling af relapser i perioder på op til 28 dage har været vel tolereret hos patienter, der fik Extavia.

Relapsing-remitting MS is characterized by unpredictable relapses followed by periods of months to years of relative quiet(remission) with no new signs of disease activity.
Den relapserende-remitterende type er karakteriseret ved uforudsigelige attakker efterfulgt af perioder på måneder eller år, hvor sygdommen forholder sig nogenlunde rolig(remission) uden nye tegn på sygdomsaktivitet.

In both trials secondary progressive multiple sclerosis patients receiving Extavia showed a reduction in frequency(30%) of clinical relapses.
I begge forsøg oplevede patienter med sekundær progressiv dissemineret sklerose en reduktion i hyppighed(30%) af kliniske relapser.

prolongs the time without relapses.
forlænger perioden uden opblussen.

interferon beta seems to calm the immune system down and prevent relapses of MS.
det ser ud til, at interferon- beta dæmper immunsystemet og forhindrer attakker af dissemineret sklerose.

Rebif was more effective than placebo in reducing the number of relapses in relapsing-remitting MS.
Rebif var mere effektivt end placebo til at mindske antallet af attakker ved recidiverende- remitterende dissemineret sklerose.

severity of clinical relapses, as well as the number of hospitalisations due to disease.
sværhed af kliniske relapser såvel som en reduktion i antallet af hospitalsindlæggelser på grund af sygdommen.

In Phase 3 MS clinical trials, concomitant treatment of relapses with a short course of corticosteroids was not associated with an increased rate of infection.
I kliniske fase III studier hos MS- patienter var en samtidig kort kortikosteroid behandling af attakker ikke associeret med en øget hyppighed af infektioner.

In both trials secondary progressive multiple sclerosis patients receiving Betaferon showed a reduction in frequency(30%) of clinical relapses.
I begge undersøgelser viste patienter med sekundær progressiv dissemineret sklerose en reduktion i hyppighed(30%) af kliniske relapser.

TYSABRI is indicated as a single disease modifying therapy in relapsing remitting multiple sclerosis to prevent relapses and delay progression of disability.
TYSABRI er indiceret som en monoterapeutisk sygdomsmodificerende behandling hos patienter med relapsing- remitting multipel sklerose for at forhindre attakker og for at forsinke progression af handikapudvikling.

People with relapsing-remitting MS have occasional attacks or relapses during which symptoms become noticeably worse.
Patienter med recidiverende- remitterende dissemineret sklerose har periodevise attakker eller relapser, hvor under hvilke symptomerne bliver mærkbart værre.